TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
INCY

Incyte Corporation

Healthcare · Biotechnology

121.40$ -1.5% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 1,413 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCY
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
16 19 36 -21 -7.3 -47 -58 -118 -115 -102 -50 -93 -141 12 98 -162 -95 9.2 26 87 305 -93 336 711 -125 749 970 496 335 1,413
6.5 10 18 25 35 48 23 18 14 8.2 7.4 13 13 17 24 27 30 29 41 45 58 52 55 55 52 58 68 83 89 93
– – – – – – 4.1 4.1 0.5 0.2 8.9 8.9 15 10.0 15 29 38 38 62 70 96 133 148 167 178 183 188 216 266 249
– – – – – – – – – – – – – – – 29 38 68 62 73 117 226 174 186 201 -266 275 – – –
13 -2.1 2.2 -25 -6.2 -25 28 -22 -3.7 -6.1 13 -20 9.5 154 87 -31 -118 -4.5 -29 -35 25 -64 -47 57 -72 -15 199 -249 138 -527
20 26 35 35 96 13 12 9.7 1.4 1.6 1.6 1.2 0.7 0.4 4.1 3.8 2.8 4.3 28 26 120 111 73 78 187 181 78 47 86 59
-20 -65 -45 -8.7 -534 -26 41 126 -77 16 26 170 106 16 15 -2.5 -2.0 -37 -138 -105 -232 -350 -86 -87 -269 -208 -79 -208 158 -103
– – – – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 17 23 30 26 – – –
– – – – – – -5.7 -0.1 – – – – – – – 19 48 73 93 86 50 716 30 -17 -23 -30 -26 -29 -2,005 -19
– – – – – – – – – – – – – – – – – 214 0.2 -1.7 14 0.0 -0.8 -0.8 -0.8 -2.4 -2.9 -3.4 -3.8 -4.5
1.5 90 4.0 13 619 5.8 -3.2 -1.2 294 -34 32 12 105 242 -145 19 48 276 93 88 59 690 15 46 72 6.2 -0.8 -20 -2,022 101
-2.9 44 -5.6 -18 78 -67 -20 6.8 102 -121 7.4 90 70 271 -32 -145 -49 247 -19 69 131 247 265 669 -319 544 894 262 -1,526 1,410
-4.2 -7.4 1.5 -56 -104 -60 -70 -128 -116 -104 -52 -94 -142 12 94 -166 -98 4.9 -1.6 61 184 -204 263 633 -312 568 892 449 249 1,355

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?